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To understand the pathogenicity of acquired immune deficiency syndrome (AIDS), it is
important to clarify where, when and how the virus replicates in the body of infected
individuals. To identify the major virus replication site at the end stage of SHIV infection,
we investigated the systemic tissues of SHIV-infected monkeys that developed AIDS-like
disease. We quantified proviral DNA, and compared the mutation patterns of the viruses
in various systemic tissues and in peripheral blood through phylogenetic analysis of the
full genome sequence. We found that the amounts of proviral DNA detected in internal
tissues were higher than those in peripheral blood mononuclear cells. In the sequence
and phylogenetic tree analyses, the mutation patterns of the viruses in each tissue were
generally different. However, the mutation pattern of the viruses in the jejunum and
mesenteric lymph node were most similar to that of plasma viral RNA among the tissues
examined in all three monkeys. In two of the three monkeys, which were euthanized
earlier, viruses in the jejunum and mesenteric lymph node occupied the root position of
the phylogenetic tree. Furthermore, in these tissues, more than 50% of SHIV-expressing
cells were identified as macrophages based on co-expression of CD68. These results
suggest that macrophages of the small intestine and/or mesenteric lymph node are the
major virus production site at the end stage of SHIV infection of macaques.
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INTRODUCTION
To understand the pathogenicity of AIDS, it is important to clar-
ify where, when and how HIV replicates in the body of infected
individuals. However, there are limitations to analysis of sys-
temic human tissues. Animal models can substitute for humans;
i.e., the simian immunodeficiency virus (SIV)-macaque model.
SIV-infected macaques develop AIDS-like disease at an interval
from several months to years (Desrosiers, 1990). However, SIV is
closely related to HIV-2, but not HIV-1; in particular, the immune
response of SIV env is thought to be different from the immune
response of HIV-1 (Overbaugh et al., 1991).
Another animal model is that comprising simian-human
immunodeficiency virus (SHIV) and the macaque. SHIVs are
chimeric viruses that contain HIV-1 env, rev, tat, and vpu genes
on a background of SIVmac, and some strains of SHIV cause
AIDS-like disease (Reimann et al., 1996, 1999; Joag et al., 1997;
Harouse et al., 1998). One such virus is SHIV-KS661, which is
characterized by the profound depletion of CD4+ T cells and
maintenance of high viral loads (Fukazawa et al., 2008). The
SHIV-macaque model has two main merits. First, SHIVs contain
HIV-1 env, rev, tat, and vpu genes (Kuwata et al., 1995), and it is
especially important that the env gene is from HIV-1. SHIVs are
reported to include both CXCR4-tropic and CCR5-tropic strains;
CXCR4-SHIV targets the peripheral blood and thymus, whereas
CCR5-SHIV targets gut-associated lymphoid tissues (Harouse
et al., 1999; Ho et al., 2005), although most known SIV strains
are CCR5-tropic. Therefore, this would be a useful approach to
understanding the cell tropism and pathogenesis of the env gene
of HIV-1. The second advantage of using the SHIV-macaque
model is that it is easy to evaluate pathogenesis because the dis-
ease progresses more quickly in CXCR4-SHIV-infected macaques
compared to SIV-infected macaques. SHIV-infected macaques
develop CD4+ T cell depletion within several weeks, and acute
AIDS-like disease from several weeks to months (Joag et al., 1996;
Reimann et al., 1996).
Previous studies using the SIV-macaque model of AIDS have
demonstrated that SIV replicates rapidly around the intestine
during primary infection, within a couple of weeks post-infection
(Veazey et al., 1998; Li et al., 2005; Mattapallil et al., 2005).
Moreover, CD4+ T cell depletion upon primary infection with
HIV-1 has been reported to occur in the gastrointestinal tract
(Meng et al., 2000; Brenchley et al., 2004; Mehandru et al., 2004).
However, the dynamic states of the virus during other phases,
especially the AIDS stage, have not been defined.
During primary infection of SIV or SHIV, the virus-producing
site has been defined by quantification of proviral DNA and
viral RNA using quantitative PCR and plaque assay in systemic
tissues (Couedel-Courteille et al., 1999, 2003; Miyake et al.,
2004). However, because the viruses were detected in systemic
tissues at high levels during the AIDS stage, it was difficult to
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identify the site of virus production by only quantification of
proviral DNA and viral RNA. Therefore, we focused on the
nucleotide mutations of virus in systemic tissues and in periph-
eral blood, and examined the viral dynamics in SHIV-infected
macaques at the end stage. Previous studies have analyzed the
viral sequences in several tissues of infected individuals and sug-
gested that HIV and SIV evolve differentially in those tissues
(Kodama et al., 1993; Wong et al., 1997; Oue et al., 2013).
However, they did not define the major site of virus produc-
tion because analyzed tissues were limited. Based on previous
reports, we hypothesized that the site of virus replication might
be determined by phylogenetic analyses. In this study, direct
sequencing of the full SHIV genome was performed to detect
mutations, and a consensus sequence was determined for each
tissue and for peripheral blood. Then, phylogenetic analyses were
performed to compare the virus sequence patterns among tissues.
Furthermore, we conducted an immunohistochemical analysis
of virus-producing cells. Based on these analyses, we identi-
fied the major virus replication site at the end stage of SHIV
infection.
MATERIALS AND METHODS
VIRUSES
We used the molecular clone viruses, SHIV-KS661 (GenBank
accession no. AF217181) and SHIV-KS705. SHIV-KS661was con-
structed from the consensus sequence of SHIV-C2/1. SHIV-C2/1
was generated by in vivo passage in cynomolgus monkey (Macaca
fascicularis) of SHIV-89.6 (containing env, tat, rev and vpu gene
of HIV-1) (Shinohara et al., 1999).
SHIV-KS661 causes rapid and profound depletion of CD4+
T cells. In this study, the SHIV-KS661 virus stock was prepared
by two methods. In method 1, SHIV-KS661 was prepared from
culture supernatants of COS-1 cells by direct transfection with a
molecular clone. In method 2, it was prepared from the super-
natants of a human cell line, CEMX174 by infection with the
virus of method 1. SHIV-KS705 is a chimeric virus of SHIV-
KS661 and SHIV-#64, and contains the env gene of SHIV-KS661
(SphI∼XhoI fragment) in a SHIV-#64 background. SHIV-#64
was amolecular clone derived from SHIV-89.6P, which was gener-
ated by in vivo passage of SHIV-89.6 in rhesus monkeys (Macaca
mulatta) (Kozyrev et al., 2001). The SHIV-KS705 stock was pre-
pared from the supernatant of culture of a human cell line, M8166
by infection with the virus of method 1. There was no serious
influence of the virus preparation on the results.
MONKEYS AND INOCULATION
Three Indian rhesus macaques were used. Throughout the exper-
imental period, the monkeys were treated in accordance with
the institutional regulations approved by the Committee for
Experimental Use of Non-human Primates at the Institute for
Virus Research, Kyoto University. Monkey MM273 was inocu-
lated intravenously with 1.2 × 104 TCID50 SHIV-KS661; MM376
was inoculated intrarectally with 2000 TCID50 SHIV-KS661, and
MM340 was inoculated intravenously with 104 TCID50 SHIV-
KS705. All three monkeys (MM340, MM376 and MM273) devel-
oped AIDS-like disease and were euthanized at 22, 33, and 90
weeks post-inoculation (wpi), respectively.
SAMPLE COLLECTION
Blood was collected under ketamine anesthesia. After the sepa-
ration of plasma, peripheral blood mononuclear cells (PBMC)
were separated from anticoagulated blood with Lymphocyte
Separation Solution (Nacalai Tesque, Kyoto, Japan) by den-
sity gradient centrifugation. Plasma and PBMC were frozen
at −80◦C until analysis. Intravenous pentobarbital (Nembutal;
Abbott Laboratories, Abbott Park, IL) (40mg/kg) was admin-
istered for deeper anesthesia. Following thoracotomy, the right
atrium was incised, and 1000ml of sterile heparinized saline
(5 U/ml) was infused into the left ventricle using an 18-gauge
needle attached to infusion tubing. Following perfusion, systemic
organs were obtained. Organ samples were frozen at −80◦C until
used for quantification of proviral DNA.
QUANTIFICATION OF PLASMA VIRAL RNA
Virion-associated SHIV RNA loads in plasma were measured by
real-time reverse transcription (RT)-PCR assay (Suryanarayana
et al., 1998; Motohara et al., 2006). Briefly, total RNA was pre-
pared from plasma (140µl) of each monkey using a QIAamp
Viral RNA Kit (Qiagen, Hilden, Germany). RT reactions and PCR
were performed using the Platinum® qRT-PCR ThermoScript™
One-Step System (Invitrogen, Carlsbad, CA) for the SIV gag
region using the following primers: SIV2-696F (5′-GGAAATTAC
CCA GTA CAA CAA ATA GG-3′) and SIV2-784R (5′-TCT ATC
AAT TTT ACC CAG GCA TTT A-3′). A labeled probe, SIV2-
731T (5′-Fam-TGTCCACCTGCCATT AAGCCCG-Tamra-3′),
was used for detection of the PCR products. These reactions
were performed using a Prism 7700 Sequence Detector (Applied
Biosystems, Foster City, CA) and analysed using the manufac-
turer’s software. A standard curve was generated from dilutions
whose copy numbers were known, and the RNA in the plasma
samples was quantified based on this standard curve.
QUANTIFICATION OF PROVIRAL DNA
The proviral DNA loads in tissues were determined by quan-
titative PCR, as described previously (Motohara et al., 2006).
DNA samples were extracted directly from frozen tissues using
a DNeasy® Tissue Kit (Qiagen). PCR was performed with
Platinum® Quantitative PCR SuperMix-UDG (Invitrogen) using
the same primer set and probes that were used for RT-PCR.
A standard curve was generated from a plasmid DNA sam-
ple containing the full genome of SHIV-KS661, which was
quantified using a UV-spectrophometer. Tissue DNA sam-
ples were also quantified using a UV-spectrophometer to use
1µg for each reaction and detection limit of this assay was
10 copies/µg.
FLOW CYTOMETRY
The frequency of CD4-positive T cells in peripheral blood was
examined by flow cytometry. Lymphocytes were treated with
anti-CD3 (FN-8-FITC; Biosource, Camarillo, CA) and anti-CD4
(Nu-TH/I-PE; Nichirei, Tokyo, Japan) monoclonal antibodies
and examined using a FACScan analyser (Becton Dickinson
Biosciences). The absolute number of lymphocytes in the blood
was determined using an automated blood cell counter (F-820;
Sysmex, Kobe, Japan).
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SEQUENCE ANALYSIS
Total DNA was extracted from the cell pellet with a DNeasy®
Tissue Kit. Total RNA was extracted from the cell pellet with a
RNeasy Protect Kit (Qiagen). RNA extraction was performed in
the condition adding DNase I to exclude the possibility of con-
tamination of proviral DNA into RNA. Virion RNA was prepared
from plasma using a QIAamp Viral RNA Kit (Qiagen). Seventy-
four consensus primers were synthesized for every 250–300 bp
throughout the genome of SHIV for full genome sequencing of
both the forward and reverse strands. Using these primers with
RNA samples, RT-PCR was performed using the One-step RT-
PCR Kit (Qiagen). For DNA samples, PCR was performed using
Platinum® PCR SuperMix (Invitrogen). The PCR products were
purified using QIAquick Spin (Qiagen) and direct sequencing
was carried out using the ABI PRISM® Big Dye® Terminator
v1.1 Cycle Sequencing Kit (Applied Biosystems) with an auto-
mated sequencer (ABI PRISM 310 genetic analyser; PerkinElmer,
Emeryville, CA).
PHYLOGENETIC ANALYSIS
Sequence alignments were performed using the ClustalW pro-
gram (Thompson et al., 1997). Final tree topologies were visu-
alized with Tree View.
IMMUNOHISTOCHEMICAL ANALYSIS
The tissue samples obtained from sacrificed monkeys were fixed
in 4% paraformaldehyde (PFA)-PBS (1× phosphate-buffered
saline) at 4◦C overnight, and embedded in paraffin wax. For
immunohistochemistry, 4-µm sections were rehydrated and pro-
cessed for 10min in an autoclave in 10mM citrate buffer (pH 6.0)
to unmask the antigens. The samples were treated sequentially
with TBS (Tris-buffered saline)-0.05% Tween 20 and 3% aqueous
hydrogen peroxide. Anti-SIV Nef mouse monoclonal antibody
(FIT Biotech, Tampere, Finland) reactions were conducted at
4◦C overnight. After washing with TBS-0.05% Tween 20, sections
were incubated at room temperature for 1 h with Envision+ Kit,
a horseradish peroxidase-labeled anti-mouse immunoglobulin
polymer (DAKO Corp., Carpinteria, CA). Subsequently, the reac-
tion was visualized using diaminobenzidine substrate (DAKO) as
a chromogen at room temperature for 5min. Samples were then
rinsed in distilled water and counterstained with hematoxylin.
To detach the primary antibody from enzymatic-
immunostained sections, those sections were washed three
times in 0.2M glycine (pH 2.2) buffer for 2 h each at room
temperature. The sections were processed for 10min in an
autoclave in 10mM citrate buffer (pH 6.0), and were then
incubated with anti-human CD3 rabbit polyclonal antibody
(DAKO) and anti-human CD68 mouse monoclonal antibody
(DAKO) at room temperature. Anti-rabbit IgG antibody-labeled
Alexa 488 and anti-mouse IgG antibody-labeled Alexa 594 were
used as secondary antibodies. Multiple staining samples were
observed with a Leica confocal microscope.
RESULTS
INFECTION OF MACAQUE MONKEYS WITH SHIV-KS661 OR SHIV-KS705
Two of three macaque monkeys, MM273 and MM376, were
inoculated intravenously and intrarectally with SHIV-KS661,
respectively. The other macaque monkey, MM340, was inocu-
lated intravenously with SHIV-KS705. In all monkeys, plasma
viral RNA increased rapidly after inoculation, and reached peak
levels of ∼108 copies/ml at 2 weeks post-inoculation (wpi). After
that, plasma viral RNA decreased to ∼106 to 107 copies/ml and
was maintained at >106 copies/ml (Figure 1A). The number of
CD4+ T cells declined to ∼200 cells/µl at 3 weeks after inoc-
ulation, and remained at zero level throughout the infection in
MM376 and MM340, whereas in MM273, the number of CD4+
T cells recovered to ∼300 cells/µl from 12 to 20 wpi, but after 46
wpi, it maintained a zero level (Figure 1B). All monkeys showed
acute diarrhea and had lost weight at the time of euthanasia.
MM340, MM376, and MM273 were euthanized at 22, 33, and
90wpi, respectively.
QUANTIFICATION OF PROVIRAL DNA IN SYSTEMIC TISSUES
Proviral DNA in systemic tissues was quantified by quantita-
tive PCR (Figure 2). In all three monkeys, the proviral DNA
was detected at high levels in the intestinal tract (jejunum and
rectum), as well as lymph nodes (axillary LN, inguinal LN,
mesenteric LN and colon LN); the proviral DNA level in lung
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FIGURE 1 | (A) Plasma viral RNA load and (B) CD4+ T cell count in peripheral blood of three SHIV-inoculated monkeys. Monkey MM340 inoculated with
SHIV-KS705 was euthanized at 22wpi; MM376 and MM273 inoculated with SHIV-KS661 were euthanized at 33wpi and 90wpi, respectively.
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FIGURE 2 | Proviral DNA loads in systemic tissues of three
SHIV-inoculated monkeys. Viral loads were determined by quantitative
PCR and are expressed as viral DNA copy numbers per microgram of total
DNA extracted from the tissue homogenates. PBMC was not collected
from MM273. Axillary LN was not collected from MM340. Colon LN,
cerebellum, cerebrum, and tonsil were collected only from MM376.
was especially high (105 copies/µg). The level of proviral DNA
in PBMC was 103 copies/µg, which was lower than that in other
tissues. In monkey MM376, high titers of proviral DNA were
detected in the cerebellum. These results showed that the virus
infected various systemic tissues at higher levels than that in
PBMC during the AIDS stage.
SEQUENCE ANALYSIS
To compare the genotypes of viruses in systemic tissues and in
peripheral blood, direct sequencing was performed, covering the
whole genome of the viral RNA extracted from plasma and provi-
ral DNA extracted from various tissue samples. In systemic tissue
samples from MM340, 16 mutations and one nucleotide dele-
tion were detected in the whole genome of SHIV-KS705 (Table 1).
Except for one mutation in the env gene (8816th nucleotide),
all of the mutations were associated with amino acid substitu-
tions. Most mutations were detected in the spleen. For MM376,
30 mutations were detected in the whole genome of SHIV-KS661
(Table 2). Most mutations were accumulated in the rectum.
MM340 and MM376, which were euthanized earlier, showed
more mutations in systemic tissues than in peripheral blood such
as plasma and PBMC, and these occurred in the region of the
envelope gene. For MM273, 90 mutations were observed in the
whole genome of SHIV-KS661. Almost all mutations were associ-
ated with amino acid substitutions. In axillary LN, few mutations
were observed in the region of env-gp120. Also in MM273, the
number of mutations observed in peripheral blood was the same
as that in the various tissues. To compare the mutation patterns
of produced viruses with those of proviruses, viral RNA in tis-
sues of MM273 was sequenced. In the jejunum and mesenteric
LN, the regions of mutations in virus RNA and provirus DNA
were almost identical (Table 3). This suggested that the viruses
produced in tissues are the same as the provirus DNA in the
infected cells. In all monkeys, the mutation patterns of viruses
differed among tissues; in the monkey that was euthanized ear-
lier, the mutations were limited, whereas more mutations had
accumulated in the monkey euthanized later.
Moreover, in this study, two mutations of gag-matrix (569th
and 638th nucleotide) were detected in all three macaques, while
a single mutation of nef (9359th nucleotide) was detected in two
of three macaques (Tables 1–3).
PHYLOGENETIC ANALYSIS
To clarify the relationships among the genotype of viruses in sys-
temic tissues, phylogenetic analyses were performed. In MM340,
the mutations of viruses in systemic tissues and peripheral blood
exhibited different patterns, but similarities were noted among
viruses in plasma, PBMC, mesenteric LN, jejunum and lung
(Figure 3A). In MM376, the mutations of viruses in each tissue
and peripheral blood also exhibited different patterns. Similarities
were noted among viruses in plasma, jejunum, mesenteric LN,
and axillary LN (Figure 3B). In MM273, the viruses accumu-
lated many more mutations in systemic tissues. The mutation
patterns among viruses in plasma, rectum, jejunum and mesen-
teric LN showed greater relatedness than those in other tissues
(Figure 3C). In all monkeys, the genotypes of viruses related to
the small intestine, such as the jejunum and mesenteric LN, were
similar to those of viruses in peripheral blood. In the monkeys
that were euthanized earlier (MM340 and MM376), viruses from
the jejunum, mesenteric LN and peripheral blood occupied the
root position of the phylogenetic tree; whereas in the monkey that
maintained a high viral load and was euthanized later (MM273),
many mutations accumulated in each tissue independently, but
the jejunum, mesenteric LN and peripheral blood formed a clus-
ter. Additionally, virus RNA in the jejunum and mesenteric LN
also showed greater similarities with provirus DNA in those tis-
sues (Table 3). Also, in spleen, the mutation pattern of viral
RNA was almost identical to that of the provirus DNA (data not
shown).
IMMUNOHISTOCHEMICAL ANALYSIS
To identify the type of cells in which viruses replicate in the
jejunum and mesenteric LN, an immunohistochemical analy-
sis of CD3+ T cells and CD68+ macrophages in jejunum and
mesenteric LN was performed. In all monkeys, >50% of SIV
nef -expressing cells were judged macrophages according to co-
localization of CD68 in jejunum (Figure 4) and mesenteric LN
(data not shown). SIV nef -expressing CD3+ T cells were rare, and
the remaining nef -expressing cells were negative for both CD3
and CD68.
DISCUSSION
In this study, we analysed mutations across the whole SHIV
genome in systemic tissues, including the intestine, of SHIV-
KS661- or -KS705-infected macaques. Although this study has
a limitation as we could analyzed only three macaques, includ-
ing different viruses and different inoculation route, we think
common tendency observed in the three macaques is significant.
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Table 1 | Consensus nucleotide mutations in MM340.
Nucleotide KS705 Plasma PBMC Thymus Spleen Ing.LN Mes.LN Rectum Jejunum Lung Amino acid Genomic
position change region
312 T C C C C C C C C C PBS
323 T A A
543 T C V/A
gag-MA569 A G G G G G G G G G K/E
638 G A A A A A A A A A A/V
2948 C T T T T T T L/S RT
5165 C T T T T P/S
vif
5190 G R/K
6838 T G I/R
env gp120
6859 A G E/G
6906 A G S/G
7272 A G G G I/V
8624 C A A C/stop env gp41
P/T rev
8803 A G E/G env gp41
R/G nef
8816 C T T T T T T T A/A env
P/L nef
9359 A G G G G G Y/C U3
9644∼9 1bp-del 1bp-del 1bp-del
Previous studies indicated that HIV evolves differentially in vari-
ous tissues (Delassus et al., 1992; Wong et al., 1997; Buckner et al.,
2002; Ritola et al., 2004; Ndolo et al., 2005). Viruses produced
from each tissue flow into the blood. Therefore, the majority of
the circulating virus population is derived from the major pro-
duction site. We demonstrated similarities among the mutation
patterns of viruses from plasma, jejunum and mesenteric lymph
node. This suggests that the major site of virus production at the
end stage of SHIV infection of macaques is the small intestine
and/or mesenteric LN. Moreover, previous whole-body positron
emission tomography (PET) analyses of HIV-1-infected patients
and SIV-infected macaques also suggested that the intestine was
the target organ at the end stage of HIV-1/SIV infection (Scharko
et al., 1996, 2003). Therefore, our finding that the small intes-
tine is the major production site is considered to be a general
phenomenon of primate lentivirus infection, and not specific to
SHIV.
Concerning primary infection with HIV and SIV, which are
transmitted usingmainly CCR5 as their co-receptor, some reports
suggest affinity for the small intestine. It has been suggested
that CD4 lymphocytes of the intestinal tract are depleted selec-
tively during early HIV infection (Clayton et al., 1997). Veazey
et al. demonstrated that SIV eliminated intestinal CD4+ T cells
selectively (Veazey et al., 1998). Other studies demonstrated
that SIV replicated exclusively in memory CD4+ T cells and
directly destroyed memory CD4+ T cells in the small intestine
(Li et al., 2005; Mattapallil et al., 2005). Mesenteric LN har-
bored viral reservoirs that cause rebound of plasma viremia in
SIV-infected macaques upon cessation of combined antiretro-
viral therapy (Horiike et al., 2012). Another study demon-
strated that CXCR4-tropic SHIV decreased peripheral CD4+
T cells, and that CCR5-tropic SHIV decreased intestinal CD4+
T cells (Harouse et al., 1999; Ho et al., 2005). SHIV-KS661
and -KS705 have essentially the same env gene and use pre-
dominantly CXCR4 as a co-receptor for virus entry (Matsuda
et al., 2010; Fujita et al., 2013). However, SHIV-KS661 decreased
CD4+ T cells in systemic and mucosal immune tissues dur-
ing primary infection (Miyake et al., 2006). Macrophage-tropic
SHIV use CXCR4, not CCR5, for infections of rhesus macaque
peripheral blood mononuclear cells and alveolar macrophages
(Igarashi et al., 2003). In this study, we suggested that the small
intestine and/or mesenteric LN were the major virus produc-
tion site at the end stage of SHIV-KS661 and –KS705 infec-
tion, regardless of the infection route. These findings suggest
that the small intestine is the critical target organ of not only
CCR5-tropic HIV/SIV infection, but also CXCR4-tropic SHIV
infection.
Phylogenetic analysis suggested that the phylogenetic trees
differed among the three macaques. In MM340 and MM376,
viruses in the jejunum and mesenteric LN, together with viruses
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FIGURE 3 | Unrooted phylogenetic trees of consensus sequences.
Branch length is drawn to scale. (A) Phylogenetic tree demonstrating the
relationships among consensus sequences from seven tissues and
peripheral blood of monkey MM340. (B) Phylogenetic tree demonstrating
the relationships among consensus sequences from 11 tissues and
peripheral blood of MM376. (C) Phylogenetic tree demonstrating the
relationships among consensus sequences from eight tissues and
peripheral blood of MM273.
in plasma, occupied the root position of the phylogenetic tree,
whereas in MM273, the viral sequences from plasma, jejunum,
mesenteric LN and rectum did not occupy the root position,
but clustered separately from other tissues. In a phylogenetic
tree, viruses in the root position have a consensus mutation
pattern. Moreover, viruses in circulating blood tend to have
the consensus mutation pattern either because they flow from
tissues to the same degree or no particular virus produc-
tion site is predominant. Therefore, in MM340 and MM376,
viruses of the jejunum and mesenteric LN have mutation pat-
terns similar to those in plasma, suggesting that circulating
viruses accumulated in and were produced from the small intes-
tine and/or mesenteric LN. On the other hand, in MM273,
which retained a high viral load and was euthanized later,
the viral sequences from plasma, jejunum, mesenteric LN and
rectum did not occupy the root position, but clustered sep-
arately from other tissues. This suggests that the viruses in
the intestine and/or mesenteric LN were produced mainly in
MM273, and that viral production levels from other tissues were
relatively low.
Next, we investigated the phenotype of SHIV-producing cells
in the small intestine at the end stage of infection. Some stud-
ies have suggested that the target cells during the acute phase
are CCR5+ memory CD4+ T cells (Li et al., 2005; Mattapallil
et al., 2005). However, CD4+ T cells are unlikely to be the
target cell since SIV- and SHIV-infected macaques resulted in
CD4+ T cell depletion at the end stage of infection (Veazey
et al., 2000). Generally, macrophages are regarded as a reservoir
because their half-life when infected is substantially longer than
that of T cells. As a result, macrophages continue to accumu-
late HIV-1 and show replication for an extended period, even
in patients receiving combined antiretroviral therapy (Sharova
et al., 2005). Also, in SHIV-infected macaques, after depletion of
CD4+T cells, macrophages were identified as the virus producing
cells (Igarashi et al., 2001). In macaques inoculated with rapid-
progressing SIVsmm, the majority of SIV-positive cells in the
lymph nodes and gastrointestinal tract were macrophages (Brown
et al., 2007). As already reported, macrophages have the potential
to produce viruses at the end stage of infection. Our immuno-
histochemical study also demonstrated that >50% of the SIV
nef -positive cells were co-localized with CD68-positive cells in the
jejunum andmesenteric LN of the three macaques. Because CD68
is expressed in activated cells by phagocytosis and localizes on the
membrane of lysosomes, CD68-positive cells can be regarded as
macrophages. So, our results are consistent with those findings.
Taken together, our data suggest that circulating viruses accumu-
late and are produced in CD68-positive cells; i.e., macrophages,
in the small intestine and/or mesenteric LN. Sequence analyses
of virus DNA and RNA extracted from CD68-positive cells iso-
lated from jejunum and mesenteric LN should be investigated to
determine which tissue is the real major source of plasma virus in
future.
Finally, we detected two mutations of gag-matrix (569, 638)
in all three macaques, and one mutation of nef (9359) in
two of three macaques. The fixation of randomly occurring
mutants and the emergence of particular variants are caused
by selective pressure and the rate of virus turnover (Coffin,
1992). Because common mutations are often detected in SHIV-
KS661-infected macaques, these mutations may be important
for viral replication in vivo at the end stage of SHIV infec-
tion. These mutations do not necessarily lead to increased
pathogenicity in naïve macaques because these mutants were
present in the macaques after the collapse of the immune
system (Kuwata et al., 2007). Therefore, we do not think
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E F G H
FIGURE 4 | Identification of virus-producing cells in the jejunum of
two macaques (A,B,C,D: MM340, E,F,G,H: MM273).
Immunohistochemical CD3 staining (A,E; visualized in green), CD68
(macrophage) staining (B,F; visualized in red) and SIV-nef (C,G; visualized
in brown). More than 50% of SIV-nef-positive cells were co-localized with
CD68+ cells in the merged images (D,H).
that these mutations may be characterized as association with
escape from the immune system. We think they may have a sub-
stantial advantage for viral replication in CD68-positive cells;
i.e., macrophages. Previous studies about HIV-1 Gag matrix sug-
gested that gag targeting and assembly to multivesicular body
is important step to produce the virus particles in macrophage
(Ono and Freed, 2004). On the other hands, recent study about
nef mutation demonstrated that someNef variants were impaired
virus replication in monocyte-derived macrophage (Mwimanzi
et al., 2011). The significance of these mutations should be
investigated further in vitro and in vivo.
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